In a recently published study, researchers revealed that NSD2 overexpression in t(4;14) multiple myeloma (MM) redirects S-adenosylmethionine (SAM) toward excessive methylation of the epigenome, specifically histone H3K36 dimethylation.

Read More> https://multiplemyeloma.pocn.com/diagnosis/nsd2-overexpression-in-t414-multiple-myeloma-identifies-ak2-as-a-new-therapeutic-target/